About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited engages in the development, manufacture, marketing and sale of medicines and pharmaceutical related products in the People’s Republic of China (the PRC or China). Segments The company has two major business segments, namely Finished Drugs and Bulk Drugs. Finished Drugs The Finished Drugs products of the company are primarily sold in China. The existing product portfolio consists of antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicine. Of which, NBP, Oulaining, Xuanning, Duomeisu, Jinyouli, Ailineng and Nuolining are categorized as drugs of the company. The other Finished Drug products of the company, such as amoxicillin capsules, ceftriaxone sodium for injection, meropenem for injection, cefadroxil capsules, azithromycin tablets and vitamin C supplement tablets, are categorized as common generic drugs. The primary end-user customers of the company’s finished drug products include hospitals, health-care centres, clinics and pharmacy stores. The company generates revenue by selling its finished drug products to distributors which in turn sell its products to the end-user customers. Bulk Drug Bulk drug products of the company include antibiotics, vitamin C and caffeine in the bulk powder form. Apart from the market in China, a significant part of the bulk drug products is sold in overseas markets, including U.S., Germany, Japan and India. The company sells its bulk drug products to pharmaceutical companies, food and beverages manufacturers and distributors. The company focuses on the manufacturing, researching and marketing of medicines and pharmaceutical related products. The company has approximately 1,000 finished drugs products including antibiotics, cardio-cerebrovascular drugs, antipyretic analgesic drugs, digestive system drugs, oncology drugs and traditional Chinese medicine. History The company was founded in 1997. It was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in 2013.